Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells

Gynecologic and Obstetric Investigation

Volumn 75, Issue 1, 2013, Pages 9-15

  Taniguchi, Fuminori ^a   Higaki, Hiroko ^a   Azuma, Yukihiro ^a   Deura, Imari ^a   Iwabe, Tomio ^a   Harada, Tasuku ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Endometriosis; Gonadotropin releasing hormone agonist; Gonadotropin releasing hormone antagonist

Indexed keywords

ACTIN; BUSERELIN; CETRORELIX; GONADORELIN RECEPTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENDOMETRIUM CELL; ENDOMETRIUM TUMOR; FEMALE; FIBROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UTERUS TUMOR;

ADULT; BLOTTING, WESTERN; BUSERELIN; CELL PROLIFERATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTERLEUKIN-8; LEIOMYOMA; OVARIAN DISEASES; PREMENOPAUSE; RECEPTORS, LHRH; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE NEOPLASMS;

EID: 84872606170     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000343748     Document Type: Article

References (20)

1. Harada T, Iwabe T, Terakawa N: Role of cytokines in endometriosis. Fertil Steril 2001; 76: 1-10.
2. Giudice LC, Kao LC: Endometriosis. Lancet 2004; 364: 1789-1799.
3. Altintas D, Kokcu A, Tosun M, Cetinkaya MB, Kandemir B: Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis. J Obstet Gynaecol Res 2008; 34: 1014-1019.
4. Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M, Terakawa N: Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997; 176: 593-597.
5. Iwabe T, Harada T, Tsudo T, Tanikawa M, Onohara Y, Terakawa N: Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998; 69: 924-930.
6. Baker SJ, Reddy EP: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12: 1-9.
7. Taniguchi F, Harada T, Miyakoda H, Iwabe T, Deura I, Tagashira Y, Miyamoto A, Watanabe A, Suou K, Uegaki T, Terakawa N: TAK1 activation for cytokine synthesis and proliferation of endometriotic cells. Mol Cell Endocrinol 2009; 307: 196-204.
8. Sakamoto Y, Harada T, Horie S, Iba Y, Taniguchi F, Yoshida S, Iwabe T, Terakawa N: Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 2003; 88: 730-735.
9. Osteen KG, Yeaman GR, Bruner-Tran KL: Matrix metalloproteinases and endometriosis. Semin Reprod Med 2003; 21: 155-164.
10. Izawa M, Harada T, Deura I, Taniguchi F, Iwabe T, Terakawa N: Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells. Hum Reprod 2006; 21: 600-604.
11. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, Terakawa N: Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000; 85: 824-829.
12. Braun DP, Ding J, Dmowski WP: Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil Steril 2002; 78: 727-732.
13. Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N: Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril 2008; 90: 994-999.
14. Wu Y, Kajdacsy-Balla A, Strawn E, Basir Z, Halverson G, Jailwala P, Wang Y, Wang X, Ghosh S, Guo SW: Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006; 147: 232-246.
15. Grundker C, Schlotawa L, Viereck V, Eicke N, Horst A, Kairies B, Emons G: Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. Eur J Endocrinol 2004; 151: 141-149.
16. Millar RP: GnRHs and GnRH receptors. Anim Reprod Sci 2005; 88: 5-28.
17. Borroni R, Di Blasio AM, Gaffuri B, Santorsola R, Busacca M, Vigano P, Vignali M: Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate. Mol Cell Endocrinol 2000; 159: 37-43.
18. Morimoto C, Osuga Y, Yano T, Takemura Y, Harada M, Hirata T, Hirota Y, Yoshino O, Koga K, Kugu K, Taketani Y: GnRH II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 2005; 20: 3212-3218.
19. Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR, Millar RP: A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 2003; 144: 423-436.
20. Cheng CK, Leung PC: Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005; 26: 283-306.